Answers are grounded in this paper and cite their sources.
Dengue (pronounced DENgee) fever is a painful, debilitating mosquito-borne disease caused by any one of four closely related dengue viruses. Aim: To study effect of doxycycline in bleeding manifestations of dengue fever. Materials and Methods: Randomized, double blind, placebo controlled, parallel group study was conducted among 100 seropositive dengue patients, age between 18-60 years (fulfilling inclusion and exclusion criteria) at LLR hospital, Kanpur for Dec 2019 – Oct 2021. These patients were randomized into two groups (50 patients in each). One arm received doxycycline and other was given placebo. Results: Patient in case group (on doxycycline) had less bleeding manifestations in comparison to control group (on placebo), only 2% having major bleed as compared to 12% controls, that was statistically significant. But no significant difference seen in terms of minor bleeding. Hemodynamic compromise was more in control group (16%) as compared to treatment group (6%). Conclusion: Doxycycline might be having some role in reducing bleeding manifestations in dengue infected patients.
No takes yet. Share an insight, caveat, or question.
Bajpai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: